Post-earnings recap
Reported
Thu, May 7, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytomX Therapeutics reported a strong earnings surprise with an EPS of $0.26, significantly above expectations. However, there was no revenue reported, and no guidance was provided. The stock reacted positively, increasing by 1.66%, likely driven by the strong EPS performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.26 | N/A | +175.58% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.